IGFBP3 and colorectal carcinoma: Following multivariate Cox regression analysis where multiple variables were analyzed, only low levels of IGFBP3 methylation emerged as an independent risk factor for poor DFS in stage II and III CRC patients (HR = 0.49, 95% CI: 0.28–0.85, p<0.01).